Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Portfolio Pulse from Benzinga Neuro
The U.S. government has awarded Moderna Inc. a $176 million contract to accelerate the development of its bird flu vaccine, mRNA-1018, in response to rising H5N1 bird flu cases. The funding will support late-stage development and testing, with results expected later this year.
July 02, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna received a $176 million contract from the U.S. government to accelerate the development of its bird flu vaccine, mRNA-1018. This funding will support late-stage development and testing, with results expected later this year.
The significant government contract will provide Moderna with the necessary funds to expedite the development of its bird flu vaccine. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100